Cargando…
Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)
Autores principales: | Lucas, Alexander R., D’Agostino, Ralph, Jordan, Jennifer H., Reding, Kerryn W., O’Connell, Nathaniel S., Melendez, Giselle C., Salloum, Fadi N., Weaver, Kathryn E., Lesser, Glenn J., Hundley, W. Gregory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308033/ https://www.ncbi.nlm.nih.gov/pubmed/37397089 http://dx.doi.org/10.1016/j.jaccao.2023.04.002 |
Ejemplares similares
-
Intermuscular Fat Changes Are Related to Reduced Left Ventricular Ejection Fraction During Cancer Therapy (PREVENT-WF-98213)
por: Bellissimo, Moriah P., et al.
Publicado: (2023) -
Reduced Thoracic Aortic Distensibility Upon Breast Cancer Diagnosis (WF-97415 and WF-98213)
por: Suddala, Suhas, et al.
Publicado: (2023) -
Physical Activity During Breast Cancer Therapy Associates With Preserved Exercise Capacity and Cardiac Function (WF97415)
por: Bellissimo, Moriah P., et al.
Publicado: (2023) -
Both intermuscular fat and LVEF decline promote heart failure symptoms in cancer survivors
por: Reding, Kerryn W., et al.
Publicado: (2021) -
The relationship between abdominal fat and change in left ventricular ejection fraction in cancer patients
por: Reding, Kerryn W., et al.
Publicado: (2020)